Freyr Regulatory Radio
Un pódcast de Freyr Solutions
29 Episodo
-
Season 5: Episode 5 – Reporting Adverse Events Under MoCRA
Publicado: 1/3/2024 -
Season 5: Episode 4 – Safety in Focus – MoCRA Safety Substantiation
Publicado: 1/3/2024 -
Season 5: Episode 3 – Mastering Product Listing: A Comprehensive Guide to MoCRA Requirements
Publicado: 1/3/2024 -
Season 5: Episode 2 – Untangling the Responsibilities of MoCRA Agents and RPs
Publicado: 1/3/2024 -
Season 5: Episode 1 – MoCRA Facility Registration: What You Need to Know?
Publicado: 1/3/2024 -
Season 4: Episode 5 - Key Considerations for Comparative Quality Studies for the Proposed Biosimilar Product in EU
Publicado: 26/9/2023 -
Season 4: Episode 4 - Challenges in CMC Development of Biologics/Biosimilars
Publicado: 19/9/2023 -
Season 4: Episode 3 - CMC Requirements for Biologics/Biosimilars
Publicado: 12/9/2023 -
Season 4: Episode 2 - ICH Guidelines for CMC Development of Biologics/Biosimilars
Publicado: 5/9/2023 -
Season 4: Episode 1 - Introduction to Biologics/Biosimilars and Regulatory Pathways for Approval in the EU
Publicado: 29/8/2023 -
Season 3: Episode 6 - Regulatory Lifecycle Management of Medicinal Products
Publicado: 28/2/2023 -
Season 3: Episode 5 - Medicinal Products’ Intellectual Patenting
Publicado: 21/2/2023 -
Season 3: Episode 4 - US FDA’s Facilitated Regulatory Pathway and Their Significance
Publicado: 14/2/2023 -
Season 3: Episode 3 - Procedures for Medicinal Products’ Approval
Publicado: 7/2/2023 -
Season 3: Episode 2 - GDUFA & PDUFA Guidelines
Publicado: 31/1/2023 -
Season 3: Episode 1 - US Market Entry & Landscape In Regulatory Affairs
Publicado: 24/1/2023 -
Season 2: Episode 6 - Pharma Advertising and Promotions: Canada
Publicado: 14/12/2022 -
Season 2: Episode 5 - Pharma Advertising and Promotions: Mexico
Publicado: 7/12/2022 -
Season 2: Episode 4 - Pharma Advertising and Promotions: United Kingdom
Publicado: 30/11/2022 -
Season 2: Episode 3 - Pharma Advertising and Promotions: Lithuania
Publicado: 23/11/2022
Freyr is a leading, niche, full-service global Regulatory Solutions, and Services Company supporting, Large, Medium, and Small size global Life sciences companies, (Pharmaceutical | Generics | Medical Device | Biotechnology | Biosimilar | Consumer Healthcare | Cosmetics | Food and Food Supplements | Chemicals) in their entire Regulatory value-chain; ranging from Regulatory Strategy, Intelligence, Dossiers, Submissions, etc. to Post- Approval / Legacy Product Maintenance, Labeling, Artwork Change Management, and other related functions.
